High Country Bancorp, Inc. (HCBC)

Intra-Cellular Therapies Ratios and Metrics

Market cap in millions USD. Fiscal year is July - June.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Aug 1, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021	Jun 30, 2020
Market Capitalization	30	31	39	45	47	36
Market Cap Growth	-7.01%	-20.17%	-13.97%	-3.47%	27.84%	-11.80%
Last Close Price	30.00	28.37	33.47	36.40	36.03	26.51
PE Ratio	10.02	9.48	8.48	10.59	9.55	8.40
PS Ratio	1.39	1.55	1.86	2.15	2.17	2.08
PB Ratio	0.73	0.78	1.01	1.21	1.24	1.04
P/FCF Ratio	-	6.10	8.61	6.95	8.24	6.39
P/OCF Ratio	-	5.67	8.09	6.50	6.56	5.20
Debt / Equity Ratio	0.83	1.17	0.61	0.02	0.02	0.32
Debt / FCF Ratio	-	9.08	5.20	0.11	0.14	1.98
Return on Equity (ROE)	7.56%	8.38%	12.10%	11.39%	13.47%	14.06%
Return on Assets (ROA)	0.63%	0.71%	1.02%	0.99%	1.32%	1.43%
Earnings Yield	10.10%	10.55%	11.79%	9.45%	10.47%	11.90%
FCF Yield	-	16.41%	11.61%	14.39%	12.13%	15.64%
Dividend Yield	6.67%	7.05%	5.98%	5.50%	5.55%	5.66%
Payout Ratio	-	59.33%	42.11%	45.70%	40.16%	31.00%
Buyback Yield / Dilution	0.80%	-0.17%	0.87%	0.72%	-8.22%	-4.72%
Total Shareholder Return	7.46%	6.88%	6.84%	6.21%	-2.67%	0.94%

Source: S&P Global Market Intelligence. Banks template. Financial Sources.